statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Altimmune, Inc. (ALT)

The Law Offices of Frank R. Cruz reminds investors of the upcoming July 5, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Altimmune, Inc...

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of...

Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking Recovery - Contact The...

ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit

ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit PR Newswire LOS ANGELES, July 2, 2024...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT SHAREHOLDER ALERT: Pomerantz Law...

Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT

Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights - ALT Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending...

ALT Deadline: ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit

ALT Deadline: ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit ALT Deadline: ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit PR Newswire...

ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit PR Newswire BENSALEM, Pa., June 27...

Why Are Altimmune Shares Trading Lower Wednesday?

Altimmune shares are experiencing significant movement lower following the unexpected passing of Richard Eisenstadt, the company's Chief Financial Officer.
read more...

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Volume	2.17M
52-Wk High	$14.84
52-Wk Low	$2.09

ALT Altimmune Inc

About

Feed

News

Sentiment

Earnings

Fundamentals